Thermo Fisher Scientific Inc. (NYSE:TMO) gapped up before the market opened on Thursday . The stock had previously closed at $154.27, but opened at $154.80. Thermo Fisher Scientific shares last traded at $157.59, with a volume of 850,724 shares.

A number of research firms have recently weighed in on TMO. Leerink Swann reaffirmed an “outperform” rating on shares of Thermo Fisher Scientific in a research note on Monday, March 21st. Mizuho raised their price objective on Thermo Fisher Scientific from $150.00 to $160.00 and gave the company a “buy” rating in a research note on Monday, April 4th. BTIG Research reissued a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Friday, May 27th. Goldman Sachs Group Inc. raised their price objective on Thermo Fisher Scientific to $156.00 in a research note on Wednesday, March 23rd. Finally, Evercore ISI reissued a “buy” rating and issued a $145.00 price objective on shares of Thermo Fisher Scientific in a research note on Monday, March 21st. Three equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $155.43.

The company has a market capitalization of $61.80 billion and a price-to-earnings ratio of 31.60. The company’s 50 day moving average price is $150.41 and its 200-day moving average price is $141.83.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Thursday, April 28th. The company reported $1.80 EPS for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.06. The company had revenue of $4.29 billion for the quarter, compared to the consensus estimate of $4.11 billion. During the same quarter last year, the business earned $1.63 EPS. Thermo Fisher Scientific’s revenue was up 9.6% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific Inc. will post $8.13 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Thursday, September 15th will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend is Tuesday, September 13th.

In other Thermo Fisher Scientific news, VP Peter M. Wilver sold 68,200 shares of the firm’s stock in a transaction on Friday, June 10th. The stock was sold at an average price of $152.38, for a total value of $10,392,316.00. Following the sale, the vice president now owns 64,727 shares of the company’s stock, valued at approximately $9,863,100.26. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Daniel P. Shine sold 6,013 shares of the firm’s stock in a transaction on Tuesday, April 26th. The shares were sold at an average price of $146.00, for a total value of $877,898.00. Following the completion of the sale, the senior vice president now directly owns 27,892 shares in the company, valued at approximately $4,072,232. The disclosure for this sale can be found here.

Several large investors have modified their holdings of the stock. Haverford Trust Co. increased its stake in shares of Thermo Fisher Scientific by 0.5% in the fourth quarter. Haverford Trust Co. now owns 7,334 shares of the company’s stock worth $1,040,000 after buying an additional 34 shares in the last quarter. Argent Trust Co increased its stake in shares of Thermo Fisher Scientific by 0.8% in the third quarter. Argent Trust Co now owns 10,619 shares of the company’s stock worth $1,299,000 after buying an additional 80 shares in the last quarter. Ray Gerald L & Associates Ltd. increased its stake in shares of Thermo Fisher Scientific by 0.4% in the fourth quarter. Ray Gerald L & Associates Ltd. now owns 34,792 shares of the company’s stock worth $4,935,000 after buying an additional 150 shares in the last quarter. Pinnacle Associates Ltd. increased its stake in shares of Thermo Fisher Scientific by 0.4% in the fourth quarter. Pinnacle Associates Ltd. now owns 38,873 shares of the company’s stock worth $5,514,000 after buying an additional 150 shares in the last quarter. Finally, Rockefeller Financial Services Inc. increased its stake in shares of Thermo Fisher Scientific by 1.2% in the fourth quarter. Rockefeller Financial Services Inc. now owns 16,417 shares of the company’s stock worth $2,328,000 after buying an additional 194 shares in the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.